您的位置: 首页 > 农业专利 > 详情页

Use of DR3 antibodies in the treatment of inflammatory disease
专利权人:
Guo-Liang Yu
发明人:
Guo-Liang Yu,Jian Ni,Reiner L. Gentz,Patrick J. Dillon
申请号:
US12771910
公开号:
US08105589B2
申请日:
2010.04.30
申请国别(地区):
US
年份:
2012
代理人:
摘要:
The present invention relates to novel Death Domain Containing Receptor (DR3 and DR3-V1) proteins that are members of the tumor necrosis factor (TNF) receptor family. In particular, isolated nucleic acid molecules are provided encoding the human DR3 and DR3-V1 proteins. DR3 and DR3-V1 polypeptides are also provided, as are vectors, host cells and recombinant methods for producing the same. Also provided are antibodies and fragments thereof that bind to polypeptides of the invention. The invention further relates to screening methods for identifying agonists and antagonists of DR3 and DR3-V1 activity.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充